Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Planned for Nov 5, 2026 · Notice filed Nov 5, 2026
An Abbott Laboratories officer told the SEC about a plan to sell $406K of Abbott Laboratories shares around Nov 5, 2026. The filing says the shares were acquired as compensation.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
None found in footnotes
Only flagged when a footnote says so; never inferred
Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Insider selling
Traded Nov 5 · filed 1 day laterNot reported under a pre-arranged trading plan
Abbott Laboratories's EXECUTIVE VICE PRESIDENT sold $406K of Abbott Laboratories shares. The filing does not indicate a pre-arranged trading plan.
Congress
Traded Sep 17 · disclosed 43 days laterSits on House Energy and Commerce
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.